| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | Chief Medical Officer | Common Stock | 788,117 | $1,079,720 | $1.37 | 02 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 01 Feb 2024 | 2 | -$38,463 | 4 | Chief Medical Officer | 05 Feb 2024, 20:45 |
| SPRO | Spero Therapeutics, Inc. | 13 Sep 2023 | 1 | -$50,160 | 4 | Chief Medical Officer | 15 Sep 2023, 18:47 |
| SPRO | Spero Therapeutics, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Chief Medical Officer | 14 Jun 2023, 08:30 |
| SPRO | Spero Therapeutics, Inc. | 01 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 03 Feb 2023, 18:40 |
| SPRO | Spero Therapeutics, Inc. | 12 Sep 2022 | 1 | $0 | 4 | Chief Medical Officer | 14 Sep 2022, 21:49 |
| SPRO | Spero Therapeutics, Inc. | 12 Sep 2022 | 0 | $0 | 3 | Chief Medical Officer | 14 Sep 2022, 21:45 |